WL

Weidong Liu

AB Array Biopharma: 13 patents #53 of 335Top 20%
NA Novartis Ag: 4 patents #1,111 of 5,128Top 25%
LO Loxo Oncology: 3 patents #11 of 31Top 40%
IN Intermune: 2 patents #31 of 57Top 55%
Genentech: 1 patents #1,597 of 2,392Top 70%
Overall (All Time): #291,848 of 4,157,543Top 8%
16
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
11807651 Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile Charles Todd Eary, Stacey Spencer, Zack Crane, Katelyn Chando, Sylvie M. Asselin +6 more 2023-11-07
11760709 Method for preparing resorcinol through micro-channel reaction Yantao Hao, Guodong Liang, Qinqin Gao, Pengshuai Li, Ting Zhang 2023-09-19
11098064 Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbontrile Charles Todd Eary, Stacey Spencer, Zack Crane, Katelyn Chando, Sylvie M. Asselin +6 more 2021-08-24
10835533 1 -((3S,4R)-4-(3-fluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-yl)-3-(4-methyl-3-(2-methylpyrimidin-5-yl)-1-phenyl-1H-pyrazol-5-yl)urea as a TrkA kinase inhibitor Shelley Allen, Steven W. Andrews, Brian Baer, Zackary Crane, Daniel J. Watson 2020-11-17
10745419 Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile Charles Todd Eary, Stacey Spencer, Zack Crane, Katelyn Chando, Sylvie M. Asselin +6 more 2020-08-18
10729678 Preparation of and formulation comprising a MEK inhibitor Christoph Max Krell, Marian Misun, Daniel Andreas Niederer, Werner Heinz Pachinger, Marie-Christine Wolf +3 more 2020-08-04
10398683 Preparation of and formulation comprising a MEK inhibitor Christoph Max Krell, Marian Misun, Daniel Andreas Niederer, Werner Heinz Pachinger, Marie-Christine Wolf +3 more 2019-09-03
10329288 Process for preparing a compound Chong Han, Keena Lynn Green, Francis Gosselin, Michelangelo Scalone, Paul Nichols +4 more 2019-06-25
9980944 Preparation of and formulation comprising a MEK inhibitor Christoph Max Krell, Marian Misun, Daniel Andreas Niederer, Werner Heinz Pachinger, Marie-Christine Wolf +3 more 2018-05-29
9598376 Preparation of and formulation comprising a MEK inhibitor Christoph Max Krell, Marian Misun, Daniel Andreas Niederer, Werner Heinz Pachinger, Marie-Christine Wolf +3 more 2017-03-21
9562016 Preparation of and formulation comprising a MEK inhibitor Christoph Max Krell, Marian Misun, Daniel Andreas Niederer, Werner Heinz Pachinger, Marie-Christine Wolf +3 more 2017-02-07
9382212 Preparation of and formulation comprising a MEK inhibitor Christoph Max Krell, Marian Misun, Daniel Andreas Niederer, Werner Heinz Pachinger, Marie-Christine Wolf +3 more 2016-07-05
9238627 Preparation of and formulation comprising a MEK inhibitor Christoph Max Krell, Marian Misun, Daniel Andreas Niederer, Werner Heinz Pachinger, Marie-Christine Wolf +3 more 2016-01-19
8648087 N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases Joseph P. Lyssikatos, Julie Marie Greschuk, Fredrik P. Marmsater, Qian Zhao, D. David Hennings 2014-02-11
8299021 Macrocyclic inhibitors of hepatitis C virus replication Lawrence M. Blatt, Scott D. Seiwert, Steven W. Andrews, Pierre Martin, Andreas Schumacher +10 more 2012-10-30
7829665 Macrocyclic inhibitors of hepatitis C virus replication Lawrence M. Blatt, Scott D. Seiwert, Steven W. Andrews, Pierre Martin, Andreas Schumacher +10 more 2010-11-09